gnrh激动剂对绝经前乳腺癌患者卵巢功能的保护meta分析-meta - analysis of gnrh agonist protection on ovarian function in premenopausal breast cancer patients.docx

gnrh激动剂对绝经前乳腺癌患者卵巢功能的保护meta分析-meta - analysis of gnrh agonist protection on ovarian function in premenopausal breast cancer patients.docx

  1. 1、本文档共33页,可阅读全部内容。
  2. 2、有哪些信誉好的足球投注网站(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。
  3. 3、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载
  4. 4、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
查看更多
gnrh激动剂对绝经前乳腺癌患者卵巢功能的保护meta分析-meta - analysis of gnrh agonist protection on ovarian function in premenopausal breast cancer patients

GnRH 激动剂对绝经前乳腺癌患者卵巢功能的保护:Meta 分析 中文摘要一、目的系统评价 GnRH 激动剂对绝经前乳腺癌患者卵巢功能的保护作用。 二、方法 计算机检索 PubMed、MEDLINE(通过 OVID 平台检索)、CENTRAL(The Coehrane Central Register of Controlled Trials)和 CBM、CNKI、VIP、万方等数据 库。收集绝经前乳腺癌患者辅助化疗联合 GnRH-a 的随机对照试验,采用 Stata11.2 软件对资料进行 Meta 分析。三、结果 共纳入 7 篇文章,8 个研究,677 例患者。Meta 分析结果显示,GnRH-a 联合辅助化疗与单纯辅助化疗相比,月经复潮率的合并 OR 值为 2.83(95%CI: 1.52 5.25),差异有统计学意义。四、结论与单纯辅助化疗相比较,联合 GnRH-a 辅助化疗对绝经前女性患者的 卵巢功能具有一定的保护作用。【关键词】Meta 分析,乳腺癌,卵巢功能,GnRH,随机对照试验Gonadotropin-releasing Hormone Analog Cotreatment For The Preservation of Ovarian Function During Gonadotoxic Chemotherapy For Breast Cancer: A Meta-AnalysisABSTRACTOBJECTIVE: To determine whether gonadotropin-releasing hormone (GnRH) analog cotreatment with chemotherapy for breast cancer provides better reproductive outcomes for women at risk of premature ovarian failure (POF) as a side-effect of gonadotoxic chemotherapy by meta-analysis.METHODS: Randomized controlled trials( RCTs) comparing GnRH cotreatment with chemotherapy alone in premenopausal women in the following electronic data-bases: Pubmed, MEDLINE(OVID), CENTRAL(The Coehrane Central Register of Controlled Trials), CBM, CNKI, VIP, and Wanfang data base were searched. All the data were analyzed by Stata 11.2.RESULTS: Seven studies involving a total of 677 participants met the inclusion criteria. The outcomes of meta-analysis implied that: Compared with adjuvant chemotherapy alone, the incidence of spontaneous menstruation demonstrated a statistically significant difference in favor of the GnRH cotreatment (OR 2.83;95% CI, 1.52-5.25).CONCLUSIONS: Evidence from RCTs suggests a potential benefit of GnRH cotreatment with chemotherapy in premenopausal women, with higher rates of spontaneous resumption of menses.Key Words: meta-analysis; breast cancer; ovarian function; gonadotrophin-releasing hormone; randomized trial英汉缩略词对照表英文缩写英文全称中文名词GnRHaGonadotropin-releasing Hormone Analog促性腺激素释放激素类似物RCTRandomized Controlled Trial随机对照试验POFPremature ovarian failure卵巢功能早衰ITTI

您可能关注的文档

文档评论(0)

peili2018 + 关注
实名认证
内容提供者

该用户很懒,什么也没介绍

1亿VIP精品文档

相关文档